Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFEPRIM: Safety of Primaquine + AL in G6PD Deficient Males
NCT02174900Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Oct 2014
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of primaquine in malaria, sponsored by London School of Hygiene & Tropical Medicine. Started Oct 2014; status: completed.
02
Drugs
primaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02174900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02174900.